These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 1715102

  • 21. Sentinel lymph node dissection for prostate cancer: experience with more than 1,000 patients.
    Weckermann D, Dorn R, Trefz M, Wagner T, Wawroschek F, Harzmann R.
    J Urol; 2007 Mar; 177(3):916-20. PubMed ID: 17296375
    [Abstract] [Full Text] [Related]

  • 22. PCA3 score before radical prostatectomy predicts extracapsular extension and tumor volume.
    Whitman EJ, Groskopf J, Ali A, Chen Y, Blase A, Furusato B, Petrovics G, Ibrahim M, Elsamanoudi S, Cullen J, Sesterhenn IA, Brassell S, Rittenhouse H, Srivastava S, McLeod DG.
    J Urol; 2008 Nov; 180(5):1975-8; discussion 1978-9. PubMed ID: 18801539
    [Abstract] [Full Text] [Related]

  • 23. Micro-focal prostate cancer: a comparison of biopsy and radical prostatectomy specimen features.
    Boccon-Gibod LM, Dumonceau O, Toublanc M, Ravery V, Boccon-Gibod LA.
    Eur Urol; 2005 Dec; 48(6):895-9. PubMed ID: 16125298
    [Abstract] [Full Text] [Related]

  • 24. [Preoperative assessment of tumor aggressiveness in localized prostatic carcinoma].
    Hammerer P, Henke RP, Hübner D, Huland H.
    Urologe A; 1995 Sep; 34(5):413-8. PubMed ID: 7483160
    [Abstract] [Full Text] [Related]

  • 25. [The role of prostate specific antigen in diagnosis of localized adenocarcinoma of the prostate. Nara Uro-Oncology Research Group].
    Hirao Y, Ozono S, Kagebayashi Y, Yoshi M, Tani Y, Uemura H, Momose H, Okajima E.
    Hinyokika Kiyo; 1996 Oct; 42(10):795-804. PubMed ID: 8951478
    [Abstract] [Full Text] [Related]

  • 26. Incidence of positive pelvic lymph nodes in patients with prostate cancer, a prostate-specific antigen (PSA) level of < or =10 ng/mL and biopsy Gleason score of < or =6, and their influence on PSA progression-free survival after radical prostatectomy.
    Weckermann D, Goppelt M, Dorn R, Wawroschek F, Harzmann R.
    BJU Int; 2006 Jun; 97(6):1173-8. PubMed ID: 16686707
    [Abstract] [Full Text] [Related]

  • 27. Characterization of minute adenocarcinomas of prostate at radical prostatectomy.
    Truskinovsky AM, Sanderson H, Epstein JI.
    Urology; 2004 Oct; 64(4):733-7. PubMed ID: 15491711
    [Abstract] [Full Text] [Related]

  • 28. The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens.
    Marks RA, Koch MO, Lopez-Beltran A, Montironi R, Juliar BE, Cheng L.
    Hum Pathol; 2007 Aug; 38(8):1207-11. PubMed ID: 17490720
    [Abstract] [Full Text] [Related]

  • 29. Radial distance of extraprostatic extension measured by ocular micrometer is an independent predictor of prostate-specific antigen recurrence: A new proposal for the substaging of pT3a prostate cancer.
    Sung MT, Lin H, Koch MO, Davidson DD, Cheng L.
    Am J Surg Pathol; 2007 Feb; 31(2):311-8. PubMed ID: 17255778
    [Abstract] [Full Text] [Related]

  • 30. [Clinical and pathological study of tumor marker in benign prostatic hypertrophy and incidental prostatic cancer].
    Sakai N, Ogawa T, Ishibashi Y, Fukuoka H, Sakanishi S.
    Hinyokika Kiyo; 1991 Jun; 37(6):589-94. PubMed ID: 1716409
    [Abstract] [Full Text] [Related]

  • 31. Predictors of Gleason pattern 4/5 prostate cancer on prostatectomy specimens: can high grade tumor be predicted preoperatively?
    Rubin MA, Mucci NR, Manley S, Sanda M, Cushenberry E, Strawderman M, Montie JE, Bassily NH.
    J Urol; 2001 Jan; 165(1):114-8. PubMed ID: 11125378
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. The extent of lymphadenectomy for pTXNO prostate cancer does not affect prostate cancer outcome in the prostate specific antigen era.
    DiMarco DS, Zincke H, Sebo TJ, Slezak J, Bergstralh EJ, Blute ML.
    J Urol; 2005 Apr; 173(4):1121-5. PubMed ID: 15758719
    [Abstract] [Full Text] [Related]

  • 37. Experience improves staging accuracy of endorectal magnetic resonance imaging in prostate cancer: what is the learning curve?
    Latchamsetty KC, Borden LS, Porter CR, Lacrampe M, Vaughan M, Lin E, Conti N, Wright JL, Corman JM.
    Can J Urol; 2007 Feb; 14(1):3429-34. PubMed ID: 17324322
    [Abstract] [Full Text] [Related]

  • 38. Can the number of cores with high-grade prostate intraepithelial neoplasia predict cancer in men who undergo repeat biopsy?
    Naya Y, Ayala AG, Tamboli P, Babaian RJ.
    Urology; 2004 Mar; 63(3):503-8. PubMed ID: 15028446
    [Abstract] [Full Text] [Related]

  • 39. Patterns of positive specimen margins and detectable prostate specific antigen after radical perineal prostatectomy.
    Weldon VE, Tavel FR, Neuwirth H, Cohen R.
    J Urol; 1995 May; 153(5):1565-9. PubMed ID: 7536268
    [Abstract] [Full Text] [Related]

  • 40. Impact of patient age on biochemical recurrence rates following radical prostatectomy.
    Magheli A, Rais-Bahrami S, Humphreys EB, Peck HJ, Trock BJ, Gonzalgo ML.
    J Urol; 2007 Nov; 178(5):1933-7; discussion 1937-8. PubMed ID: 17868723
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.